Bonita Franklin, DO
Pain Medicine · Tulsa, OKNPI 1427477140
Payments from drug & device makers
What this record shows
Saluda Medical Americas, Inc. accounts for 60.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,839, 8.2 times the $225 reported in 2020.
Across 23 payments — averaging $128.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$2K
- Medtronic$885
- SPR Therapeutics, Inc$208
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
- Pacira Pharmaceuticals Incorporated$21
- Appliedvr Inc$20
What the payments were for
- Travel & lodging$1,60254%
- Food & beverage$1,35146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 3 | $1,791 |
| Medtronic(2 entities) | 12 | $885 |
| SPR Therapeutics, Inc | 5 | $208 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Appliedvr Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,778
- INTELLIS$331
- INTELLIS ADAPTIVESTIM$261
How this compares
$2,953 in reported general payments places this provider in the 55th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 22 | $18,258 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 686 | $15,969 |
| Buprenorphine | 36 | $6,519 |
| Buprenorphine Hcl | 71 | $3,543 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 126 | $3,279 |
| Gabapentin | 202 | $2,285 |
| Tizanidine Hcl | 184 | $1,848 |
| Diclofenac Sodium | 75 | $1,111 |
| Pregabalin | 55 | $831 |
| Baclofen | 68 | $507 |
| Oxycodone Hcl | 30 | $445 |
| Tramadol Hcl | 45 | $398 |
| Promethazine Hcl | 12 | $294 |
| Diclofenac Potassium | 12 | $244 |
| Cyclobenzaprine Hcl | 32 | $240 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Tulsa
- Brian TorgersonTulsa$13K
- Lam NguyenTulsa$11K
- Jayen PatelTulsa$10K
- Hugo SalgueroTulsa$10K
- Adam WallaceTulsa$8K
- Kenneth ReedTulsa$7K
- Ahmad KhattabTulsa$7K
- David DoTulsa$6K
- Emad Attallah-WasifTulsa$4K
- Leslie ChanTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.